G16B 20/30
Detection of binding sites or motifs
G16B20/30 (Detection of binding sites or motifs) appears on 322 US grants and 887 published applications in this corpus.
Search patents in G16B- Granted patents
- 322
- Published applications
- 887
- Assignees
- 414
- Inventors
- 1,929
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 1 |
| 2002 | 4 | 9 |
| 2003 | 1 | 29 |
| 2004 | 5 | 15 |
| 2005 | 4 | 33 |
| 2006 | 3 | 42 |
| 2007 | 6 | 37 |
| 2008 | 6 | 33 |
| 2009 | 7 | 27 |
| 2010 | 13 | 24 |
| 2011 | 24 | 33 |
| 2012 | 15 | 24 |
| 2013 | 13 | 26 |
| 2014 | 21 | 30 |
| 2015 | 6 | 33 |
| 2016 | 16 | 40 |
| 2017 | 13 | 34 |
| 2018 | 14 | 34 |
| 2019 | 22 | 44 |
| 2020 | 20 | 49 |
| 2021 | 17 | 45 |
| 2022 | 17 | 50 |
| 2023 | 20 | 66 |
| 2024 | 19 | 42 |
| 2025 | 18 | 62 |
| 2026 | 12 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Genotyping by sequencing22 Sep 2026US 12,742,195 B2Regeneron Pharmaceuticals, Inc.
- Fragmentation for measuring methylation and disease22 Sep 2026US 12,742,208 B2Centre for Novostics
- Identification of convergent antibody specificity sequence patterns1 Sep 2026US 12,725,003 B2Alloy Therapeutics, Inc.
- Methods for discovering and using lymphocytes with antigen specificity18 Aug 2026US 12,709,775 B2Think Therapeutics, Inc.
- Method and system for binding affinity prediction and method of generating a candidate protein-binding peptide23 Jun 2026US 12,665,052 B2NEC Oncoimmunity AS
- Deep learning model for predicting tumor-specific neoantigen mhc class i or class ii immunogenicity27 Aug 2026US 2026/0253668 A1Amazon Technologies, Inc.
- Systems and methods for diagnosing a disease or a condition27 Aug 2026US 2026/0253670 A1Icahn School of Medicine at Mount Sinai
- Mechanistic chromatin modeling with iterative optimization, nuclear envelope interactions, and editable epigenetic composition20 Aug 2026US 2026/0245652 A1Altos Labs, Inc.
- Method for determining surface protruding amino acids of a human leukocyte antigen (hla) protein20 Aug 2026US 2026/0245653 A1Pirche AG
- Classification of samples based on methylation analysis of dna fragments13 Aug 2026US 2026/0234729 A1Foundation Medicine, Inc.
Most cited
By later US patents
- CRISPR-Cas component systems, methods and compositions for sequence manipulation560US 8,795,965 B2Massachusetts Institute of Technology · 2014
- Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites556US 6,453,242 B1Sangamo BioSciences, Inc. · 2002
- CRISPR-Cas component systems, methods and compositions for sequence manipulation529US 8,871,445 B2Massachusetts Institute of Technology · 2014
- Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation489US 8,865,406 B2Massachusetts Institute of Technology · 2014
- Engineering of systems, methods and optimized guide compositions for sequence manipulation480US 8,906,616 B2Massachusetts Institute of Technology · 2014